Logo image of STRD

STRATEGY INC - MSTR 10 PERP (STRD) Stock Fundamental Analysis

NASDAQ:STRD - US5949728613

79.46 USD
-0.54 (-0.68%)
Last: 8/29/2025, 11:10:55 AM
Fundamental Rating

3

Overall STRD gets a fundamental rating of 3 out of 10. We evaluated STRD against 282 industry peers in the Software industry. There are concerns on the financial health of STRD while its profitability can be described as average. STRD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year STRD was profitable.
In the past year STRD has reported a negative cash flow from operations.
In the past 5 years STRD reported 4 times negative net income.
STRD had a positive operating cash flow in 4 of the past 5 years.
STRD Yearly Net Income VS EBIT VS OCF VS FCFSTRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B -15B -20B

1.2 Ratios

STRD has a Return On Assets of 7.31%. This is in the better half of the industry: STRD outperforms 79.08% of its industry peers.
The Return On Equity of STRD (9.40%) is better than 76.95% of its industry peers.
The Return On Invested Capital of STRD (9.90%) is better than 85.46% of its industry peers.
Industry RankSector Rank
ROA 7.31%
ROE 9.4%
ROIC 9.9%
ROA(3y)-18.83%
ROA(5y)-14.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STRD Yearly ROA, ROE, ROICSTRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

STRD has a better Profit Margin (1023.69%) than 99.65% of its industry peers.
STRD has a better Operating Margin (1747.64%) than 100.00% of its industry peers.
STRD has a Gross Margin (70.10%) which is comparable to the rest of the industry.
STRD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1747.64%
PM (TTM) 1023.69%
GM 70.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-1.93%
STRD Yearly Profit, Operating, Gross MarginsSTRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so STRD is destroying value.
Compared to 1 year ago, STRD has more shares outstanding
STRD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for STRD has been reduced compared to a year ago.
STRD Yearly Shares OutstandingSTRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
STRD Yearly Total Debt VS Total AssetsSTRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 1.71, we must say that STRD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.71, STRD is in line with its industry, outperforming 42.55% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that STRD is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.16, STRD perfoms like the industry average, outperforming 48.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 1.71
ROIC/WACC0.95
WACC10.39%
STRD Yearly LT Debt VS Equity VS FCFSTRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B -20B

2.3 Liquidity

STRD has a Current Ratio of 0.68. This is a bad value and indicates that STRD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.68, STRD is not doing good in the industry: 83.69% of the companies in the same industry are doing better.
STRD has a Quick Ratio of 0.68. This is a bad value and indicates that STRD is not financially healthy enough and could expect problems in meeting its short term obligations.
STRD has a Quick ratio of 0.68. This is amonst the worse of the industry: STRD underperforms 83.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68
STRD Yearly Current Assets VS Current LiabilitesSTRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

STRD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2065.44%, which is quite impressive.
The Revenue has decreased by -3.81% in the past year.
STRD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.96% yearly.
EPS 1Y (TTM)2065.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5779.44%
Revenue 1Y (TTM)-3.81%
Revenue growth 3Y-3.19%
Revenue growth 5Y-0.96%
Sales Q2Q%2.73%

3.2 Future

Based on estimates for the next years, STRD will show a very strong growth in Earnings Per Share. The EPS will grow by 60.49% on average per year.
STRD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.21% yearly.
EPS Next Y-155.56%
EPS Next 2Y39.16%
EPS Next 3Y60.49%
EPS Next 5YN/A
Revenue Next Year-1.73%
Revenue Next 2Y0.6%
Revenue Next 3Y0.21%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STRD Yearly Revenue VS EstimatesSTRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
STRD Yearly EPS VS EstimatesSTRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2.33, the valuation of STRD can be described as very cheap.
Based on the Price/Earnings ratio, STRD is valued cheaply inside the industry as 98.23% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of STRD to the average of the S&P500 Index (27.17), we can say STRD is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for STRD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 2.33
Fwd PE N/A
STRD Price Earnings VS Forward Price EarningsSTRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, STRD is valued cheaply inside the industry as 98.58% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.79
STRD Per share dataSTRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 -100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as STRD's earnings are expected to grow with 60.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.16%
EPS Next 3Y60.49%

More info and screens

0

5. Dividend

5.1 Amount

STRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STRATEGY INC - MSTR 10 PERP

NASDAQ:STRD (8/29/2025, 11:10:55 AM)

79.46

-0.54 (-0.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners49.35%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap22.53B
Analysts80
Price Target121.93 (53.45%)
Short Float %0.07%
Short Ratio0.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20431.8%
Min EPS beat(2)5928.88%
Max EPS beat(2)34934.6%
EPS beat(4)2
Avg EPS beat(4)8888.46%
Min EPS beat(4)-4213.73%
Max EPS beat(4)34934.6%
EPS beat(8)3
Avg EPS beat(8)4019.14%
EPS beat(12)5
Avg EPS beat(12)-6119.95%
EPS beat(16)7
Avg EPS beat(16)-4695.93%
Revenue beat(2)0
Avg Revenue beat(2)-3.32%
Min Revenue beat(2)-6%
Max Revenue beat(2)-0.64%
Revenue beat(4)0
Avg Revenue beat(4)-4.46%
Min Revenue beat(4)-7.22%
Max Revenue beat(4)-0.64%
Revenue beat(8)1
Avg Revenue beat(8)-5.46%
Revenue beat(12)2
Avg Revenue beat(12)-4.4%
Revenue beat(16)2
Avg Revenue beat(16)-4.15%
PT rev (1m)15.95%
PT rev (3m)N/A
EPS NQ rev (1m)-3.19%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.27%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.33
Fwd PE N/A
P/S 48.73
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB N/A
EV/EBITDA 3.79
EPS(TTM)34.12
EY42.94%
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-120.51
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.63
BVpS177.64
TBVpS-49.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.31%
ROE 9.4%
ROCE 12.53%
ROIC 9.9%
ROICexc 9.91%
ROICexgc 13891.1%
OM 1747.64%
PM (TTM) 1023.69%
GM 70.1%
FCFM N/A
ROA(3y)-18.83%
ROA(5y)-14.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-1.93%
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 1.01
Cap/Depr 85616%
Cap/Sales 7370.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z 1.71
F-Score4
WACC10.39%
ROIC/WACC0.95
Cap/Depr(3y)33259.4%
Cap/Depr(5y)26278.5%
Cap/Sales(3y)1735.12%
Cap/Sales(5y)1190.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2065.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5779.44%
EPS Next Y-155.56%
EPS Next 2Y39.16%
EPS Next 3Y60.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.81%
Revenue growth 3Y-3.19%
Revenue growth 5Y-0.96%
Sales Q2Q%2.73%
Revenue Next Year-1.73%
Revenue Next 2Y0.6%
Revenue Next 3Y0.21%
Revenue Next 5YN/A
EBIT growth 1Y29493.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.67%
EBIT Next 3Y81.44%
EBIT Next 5YN/A
FCF growth 1Y-5676.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13048.8%
OCF growth 3YN/A
OCF growth 5YN/A